PTK2 and ovarian carcinoma: Recently, we demonstrated that thioridazine dramatically suppressed cell growth by inducing apoptosis, and that its angiostatic effects were mediated by the inhibition of FAK/mTOR signaling in ovarian cancer cells in vitro [6, 7].